Friday, June 19, 2015 2:04:19 PM
After reading your post I called Benchmark. I agree with you that it is worthwhile to make the call. Benchmark is of course careful to say you should do your own due diligence and that all investments are speculative etc etc, but he was able to give me some roughly estimated P/E ratio numbers which helped me get a better picture of things.
Benchmark estimated that if URHG's projected production numbers come to pass after Phase 1 and Phase 2 are complete on the first circuit, Dun Glen could produce a conservative annual revenue of about $4,000,000. With monthly expenses of $70,000-$85,000 you end up with roughly $3,000,000. Considering the outstanding shares, there would be earnings of around 2.6 cents a share. If the rule of thumb holds this could translate to a rise in the stock price up to a range of about 25-30 cents per share.
If and when a second circuit gets installed and produces at the same level, it would reasonable to estimate the stock price would then get to twice that amount, or 50-60 cents per share. Benchmark said the recent PR about additional water sources on the property are significant if URHG does add a second circuit.
- TTH
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM